Waukesha, Wis.-based GE Healthcare announces that AIR Recon DL, a deep-learning image reconstruction technology that works across all anatomies, is now U.S. FDA 510(k) cleared on Signa 7.0T MRI scanners. Since it first launched on GE Healthcare’s 3.0T and 1.5T MRI scanners, AIR Recon DL has benefited more than 500,000 patients around the world, improving the patient experience through shorter scan times while also increasing diagnostic confidence with better image quality, GE officials say.

AIR Recon DL, a deep learning image reconstruction technology, makes full use of all the raw data coming off the MRI scanner, maximizing image quality and resolution even with shorter scan times. Feedback from clinical users has been positive, including observations of sharper and less noisy images as well as a 30%-50% reduction in exam times.

“The images truly are amazing,” says Garry Gold, MD, professor of radiology at Stanford and clinical reviewer of GE Healthcare’s FDA application. “AIR Recon DL for Signa 7.0T takes everything we love about the ultra-high-field 7.0T’s strength—namely its ability to visualize high-resolution tissue structures—and brings it to the next level by reducing noise and edge ringing. As a result, AIR Recon DL with 7.0T helps reveal a more complete picture—providing greater clinical insight for improved patient outcomes and opening up new opportunities for research across various care areas.”

With a 7.0 Tesla (7.0T) magnet at its core, Signa 7.0T2 can be used for both research and clinical purposes to image anatomy, function, metabolism, and microvasculature in the brain and joints with incredible resolution and detail, for a broad range of applications across neurologic and musculoskeletal diseases. The new system features UltraG gradient technology, GE’s whole-body gradient coil with 113 mT/m and 260 T/m/s, to meet the demands of ultra-high field imaging speed, contrast, resolution, advanced diffusion, and functional brain imaging.

“We are thrilled to make our industry-leading AIR Recon DL technology available on Signa 7.0T, our most powerful scanner,” says Jie Xue, president and CEO, MR, GE Healthcare. “Signa 7.0T is a powerful tool in research for the visualization of smaller structures and subtle pathologies across various, evolving areas of study, including: neurological disorders like Alzheimer’s disease, psychological disorders like depression, and articular cartilage degradation in osteoarthritis.

Xue adds, “AIR Recon DL—which has received overwhelmingly positive user feedback and fast, broad adoption—further extends the capabilities of GE Healthcare’s completely new Signa 7.0T system, empowering our research and clinical partners to pursue new frontiers in neuroscience and musculoskeletal imaging.”

AIR Recon DL, developed on GE Healthcare’s Edison intelligence platform, is available as an upgrade or with new system purchases. It is currently available on GE Healthcare 1.5T, 3.0T, and 7.0T MR systems.